Skip to Main Content

Paper Details

Clinical testing of transcriptome-wide expression profiles in high-risk localized and metastatic prostate cancer starting androgen deprivation therapy: an ancillary study of the STAMPEDE abiraterone Phase 3 trial.
Res Sq
3
2023
Author NameAffiliation
Gerhardt AttardCancer Institute, University College London London
Yang LiuCancer Institute, University College London London
Tamara L LotanCancer Institute, University College London London
Alfonso UrbanucciNorthwestern University Feinberg School of Medicine Chicago
Edward M SchaefferUniversity Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland
Daniel E SprattQueensland University of Technology Brisbane
Daniel M BerneyMRC Clinical Trials Unit at University College London, Institute of Clinical Trials and Methodology, University College London London
Felix Y FengDana-Farber Cancer Institute Boston
Elai DavicioniManchester Cancer Research Centre, The University of Manchester Manchester
Elai DavicioniThe Christie and Salford Royal Hospitals Manchester
  • 1 - 10

Datasets